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Stromal Cell Subsets Directing 
Neonatal Spleen Regeneration
Jonathan K. H. Tan1,2,† & Takeshi Watanabe1,‡
Development of lymphoid tissue is determined by interactions between stromal lymphoid tissue 
organiser (LTo) and hematopoietic lymphoid tissue inducer (LTi) cells. A failure for LTo to receive 
appropriate activating signals during embryogenesis through lymphotoxin engagement leads to 
a complete cessation of lymph node (LN) and Peyer’s patch development, identifying LTo as a key 
stromal population for lymphoid tissue organogenesis. However, little is known about the equivalent 
stromal cells that induce spleen development. Here, by dissociating neonatal murine spleen stromal 
tissue for re-aggregation and transplant into adult mouse recipients, we have identified a MAdCAM-
1+CD31+CD201+ spleen stromal organizer cell-type critical for new tissue formation. This finding 
provides an insight into the regulation of post-natal spleen tissue organogenesis, and could be 
exploited in the development of spleen regenerative therapies.
Spleen is an organ intimately associated with blood filtration. It broadly acts in a two-fold manner to remove 
damaged or senescent red-blood cells, and to detect and respond to blood-borne pathogens1. As an immune 
organ, the capacity for spleen to filter blood means that pathogens or antigens entering the marginal zone (MZ) 
are effectively screened, enabling immediate innate or longer-lasting adaptive immune responses. This is facil-
itated by numerous immune cell types including macrophages2, monocytes3, dendritic cells (DC)4 and T and B 
cells located in the MZ, red pulp (RP) and white pulp (WP).
Establishment of organized spleen structure is essential for effective immune responses5. White pulp com-
partmentalization is organized by stromal cells, which direct hematopoietic cell populations into distinct areas of 
spleen. In white pulp, well-defined stromal cell populations include follicular dendritic cells (FDC) and fibroblas-
tic reticular cells (FRC), which organize B cell and T cell compartments, respectively6. The marginal zone which 
encircles white pulp contains a stromal layer of marginal zone reticular cells (MRC)7, that is most prominent adja-
cent to B cell follicles, but interrupted at MZ bridging channels where the marginal sinus connects directly to T 
cell areas6. Stromal tissues are not passive bystanders, with evidence that lymph node FRC populations contribute 
directly to the attenuation of T cell responses8. Furthermore, spleen stromal tissues can direct the development of 
stem cell progenitors towards antigen-presenting cell lineages9,10, and change the behavior of inflammatory DC 
into a regulatory phenotype11.
Stromal cells are also essential for lymphoid tissue organogenesis. Termed lymphoid tissue organizers, these 
stromal cells interact through lymphotoxin-β receptor (LTβ R) engagement with lymphotoxin-α 1β 2 (LTα 1β 2) 
expressed on lymphoid tissue inducer (LTi) cells, to initiate embryonic LN development12. The cascade of events 
leading from anlagen to lymphoid tissue formation have been well-described13, where maturation of local mes-
enchymal stromal cells into LTo via LTα 1β 2 signaling14 leads to expression of adhesion molecules and chemok-
ines critical for hematopoietic cell recruitment and tissue development. Moreover, LTo not only function in LN 
embryogenesis, but their activities have also been implicated in tertiary15 or artificial lymphoid tissue forma-
tion16,17. The equivalent stromal cells directing spleen development, however, remain unknown. Identification of 
such spleen organizer cells would be essential in designing specific strategies for spleen tissue regeneration. Here, 
we describe a murine model for spleen cell-aggregate graft transplantation, and report the isolation of a defined 
spleen stromal population that is essential for regeneration of neonatal spleen tissue.
Results
Establishment of a Spleen Cell Aggregate Transplant System in Mice. Lymphoid cell aggregation 
and transplantation has previously been demonstrated to represent a viable model for LN development12. To 
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adapt this protocol and investigate spleen regeneration, we isolated spleen from neonatal 3 day-old (D3) mice and 
enzymatically digested splenic stromal tissues into a single-cell solution. Cells were then re-aggregated, loaded 
over a collagen sheet, and transplanted into the kidney capsule of adult splenectomized recipient mice (Fig. 1A). 
Consistent with bulk spleen stromal tissue preparations18, grafts constructed from aggregated neonatal spleen 
cells retained the capacity to develop gross spleen tissue (Fig. 1B). Since artificial lymph nodes (aLN) have been 
previously synthesized using stromal cells loaded onto a collagen sponge16, we assessed whether D3 neonatal 
spleen cell-loaded sponges would sustain tissue formation, alongside control aggregate-sheet constructs and 
Figure 1. Development of spleen tissue from 3 day-old spleen stromal cell aggregates. (A) Schematic 
diagram of aggregate transplantation. Spleen stromal tissues from day 3 (D3) postnatal mice were isolated 
and enzymatically digested into a single-cell suspension. Cells were then aggregated and aliquoted on top 
of a collagen sheet resting over an isopore membrane/collagen sponge complex immersed in cell culture 
medium. Following overnight incubation, cell aggregate/collagen sheet constructs were transplanted under 
the kidney capsule of adult splenectomised recipient mice. (B) Macroscopic appearance of regenerated 
spleen tissue 4 weeks post-transplantation. Scale bar, 5 mm. (C) To optimize graft construction, cells derived 
from D3 spleen stromal tissue were aggregated and transplanted alone or above collagen sheets, or collagen 
sponges were loaded with equivalent cell numbers but omitting cell aggregation. Transplantation of all graft 
constructs were performed independently a minimum of 2 times, with 2–8 grafts/experiment. (D) Percent T 
and B cells in each construct 4 weeks post-transplantation was assessed by flow cytometry. Age-matched non-
surgery mouse spleen was used as a control. (E) Spleen structure of 4 week grafts or control spleen visualized 
by immunofluorescence microscopy (RP, red pulp; MZ, marginal zone. Arrows indicate central arterioles). 
Original magnification 100× . Scale bar, 200 μ m.
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non-scaffold supported aggregates (Fig. 1C). All grafts after 4 weeks displayed an influx of lymphocytes with 
percent T cells and B cells similar to native control spleen (Fig. 1D). However, only cell-aggregated grafts with or 
without collagen sheet support showed evidence of normal spleen structure, with collagen sponge grafts failing to 
organize spleen tissue (Fig. 1E). Cell to cell contact and paracrine signaling facilitated by cell aggregation there-
fore appears critical for spleen regeneration. In contrast, inflammatory stimuli required for aLN synthesis through 
enforced stromal lymphotoxin expression and addition of activated DC16 appear unnecessary factors for spleen 
regeneration, a reflection of secondary rather than tertiary lymphoid organogenesis. In all further experiments, 
aggregate-sheet constructs were used in favor of aggregates alone due to a greater level of mechanical support and 
graft stability during transplantation.
Stromal Cells Contribute Exclusively to Complete Spleen Tissue Formation. A protocol for graft 
construction using single-cell digested, and re-aggregated spleen stromal tissue allows manipulation of individual 
cell populations within grafts, which in turn permits delineation of organizer cells responsible for spleen neogen-
esis. To first identify candidate organizer cells, we examined the cell composition of neonatal D3 spleen tissue 
by immunofluorescence staining (Fig. 2) and flow cytometry analysis (Supplementary Table S1). The contribu-
tion of distinct populations towards spleen neogenesis was then screened by a series of single-marker magnetic 
cell separations, followed by graft aggregation and transplant. To confirm that stromal but not contaminating 
hematopoietic cells in spleen tissue preparations controlled de novo spleen formation, single-cell suspensions 
Figure 2. Stromal and lymphoid composition of early neonatal spleen. 3-day old spleen was cryosectioned 
and stained with indicated markers before immunofluorescence analysis to differentiate tissue micro-
architecture (RP, red pulp; MZ, marginal zone; FRC, fibroblastic reticular cells. Arrows indicate central 
arterioles). Original magnification 100× . Scale bar, 200 μ m.
www.nature.com/scientificreports/
4Scientific RepoRts | 7:40401 | DOI: 10.1038/srep40401
labeled with biotin-conjugated anti-CD45 antibody were magnetically separated into CD45+ and CD45− spleen 
fractions (Fig. 3A), with separation purity confirmed by flow cytometry (93% CD45+ cells and 98% CD45− cells, 
respectively; Fig. 3B). Each fraction was then aggregated and placed over collagen sheets before transplant. A 
semi-quantitative assessment of spleen structure including formation of RP, multiple WP follicles displaying T 
and B cell segregation, and MZ, revealed that complete spleen regeneration could only be achieved using CD45− 
stromal cell aggregates (Fig. 3C and Table 1). While tissue was also recovered from CD45-enriched aggregate 
grafts, these clearly lacked definitive spleen structure.
Selective Enrichment of Individual Stromal Cell Populations Identifies Markers Associated 
with Graft Formation. To screen for stromal cell populations carrying organizer activity, single-marker 
magnetic cell separation and aggregate transplants were performed using a panel of stromal markers (Table 1). 
Magnetic-based separations were limited by low target cell enrichment and the inability to exclude contamina-
tion from other cell populations (Table 1). However, as a screen comparing the relative capacity of single-marker 
enriched or depleted aggregates to regenerate tissue, a > 10 fold-change between negative and positive target cells 
was consistently achieved. The sensitivity of this assay to report even small sub-population target cell changes 
was demonstrated by CD31, CD105, CD201, MAdCAM-1 or PDGFRβ enriched, but not depleted aggregates, 
robustly developing spleen tissue with distinct regions of red pulp, white pulp (displaying multiple follicles/segre-
gated T and B cell areas), and marginal zones (Fig. 4). Consistent with trace tissue recovery from CD45-depleted 
aggregates (Fig. 3C), variable recovery of CD31, CD105, CD201, MAdCAM-1 or PDGFRβ depleted aggregates 
was also observed (Fig. 4), and these grafts corresponded with poor spleen compartmentalization. Overall, this 
screen generated a stromal marker profile which correlated with robust spleen regenerative capacity.
CD31+CD105+CD201+MAdCAM-1+ Stromal Cells in Spleen and are Specifically Required to 
Induce Tissue Regeneration. Based on the above marker profile, a single stromal cell population bear-
ing comparable markers was sought in vivo. Stromal cells co-expressing MAdCAM-1 and CD201 or CD31 
were evident in the marginal zone of D3 spleen (Fig. 5A), and further flow cytometric analysis confirmed a 
Figure 3. Spleen tissue regeneration from neonatal spleen stromal cell aggregates occurs independently 
of donor-derived hematopoietic cells. (A) D3 spleen stromal tissue was digested into a single-cell suspension 
and magnetically separated using biotin-conjugated anti-CD45 antibodies and anti-biotin microbeads into 
marker positive and negative fractions. (B) Separation purity was assessed by a flow cytometer using APC-
eFluor780-conjugated anti-CD45 antibody and streptavidin-PE secondary reagent. Numbers in quadrants 
indicate percent cells. (C) CD45+ and CD45− cell fractions were aggregated and placed over collagen sheets 
before transplantation and 4 week analysis by immunofluorescence microscopy using indicated markers 
(original magnification 100× , Scale bar, 200 μ m). RP, red pulp; MZ, marginal zone; CA, central arterioles. Data 
are representative of two independent experiments.
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specific CD45−CD31+CD105+CD201+MAdCAM-1+ stromal population representing putative spleen organizer 
(SPo) cells (Fig. 5B). To determine whether tissue organizer potential segregated with SPo, two-marker mag-
netic cell separation and aggregation was performed. CD31-enriched aggregates normally competent for spleen 
regeneration (Table 1) were depleted of either CD201+ or MAdCAM-1+ cells, leading to abrogation of spleen 
development (Fig. 5C). Collectively, these results supported the segregation of spleen organizer activity with 
CD31+CD201+MAdCAM-1+ cells.
To conclusively demonstrate that this candidate population represented spleen organizers, 
CD45−CD31+CD201+MAdCAM-1+ cell singlets were sorted by FACS to high purity (> 95%; Fig. 5D,E), before 
re-addition to CD201-depleted filler aggregates lacking spleen-forming potential. As controls, CD45−CD31−CD201hi 
(CD201hi) and CD45−CD31+CD201+MAdCAM-1− (MAdCAM-1−) cells were sorted in parallel. Replacement of both 
MAdCAM-1− and CD201hi cells to filler aggregates failed to rescue spleen development (Fig. 5F). However, addition 
of SPo cells restored full spleen regeneration capacity, demonstrating the specificity by which these cells function, and 
confirming that SPo represent bona fide spleen tissue organizer cells that are essential for neonatal spleen organogenesis.
SPo Express Genes Associated with Tissue Organization But Not Mesenchymal Cells. Spleen 
organizer cells express MAdCAM-1 which is consistent with classically-described LTo, yet co-expression of CD31, 
CD105 and CD201 indicates cells of a mixed endothelial/mesenchymal lineage. Indeed, LN vascular endothelial 
cells expressing MAdCAM-119, and CD105 or CD201 expression by mesenchymal stem or progenitor cells20–22 
and vascular endothelial cells (Fig. 2), further exemplify the uncertainty surrounding cell lineage determination. 
To first confirm the validity of our sorting protocol, quantitative real-time PCR was used to demonstrate specific 
Madcam expression in SPo, but not CD45−CD31+CD105+CD201+MAdCAM-1− D3 spleen stromal cells (Fig. 6). 
As expected, Pecam (CD31) was detected in both cell populations. However, expression of Nkx2.5 or HOX11 
defining spleen mesenchymal lineages23,24 was not observed. The absence of these transcription factors suggests 
SPo are distinct from mesenchymal Nkx2.5+ cells with organizer activity found in embryonic spleen23.
Supporting a functional role as tissue organizers, neonatal SPo expressed high levels of LTBR but not LTa. 
This is consistent with previous findings that neonatal spleen stromal grafts require lymphotoxin signaling to 
functionally regenerate18. TNFR1, necessary for adult spleen lymphoid compartment formation25, was also 
expressed by SPo. While we detected Rank (TRANCE-R) expression as previously described on LN stroma19, 
RankL (TRANCE) expression characteristic of LTo was absent. This result was however consistent with a general 
lack of surface staining on D3 spleen sections (Fig. 2). Similarly, CXCL13 normally produced by LTo was absent 
in SPo, in line with weak CXCL13 expression observed during neonatal spleen development7. Low level Sdf1 
(CXCL12) expression was however evident. Interestingly, differential LYVE1 expression was observed between 
MAdCAM-1+ SPo and phenotypically similar but functionally non-organizing CD31+MAdCAM-1− stromal 
cells, serving as a molecular marker to distinguish these cell subsets. LYVE-1 is normally associated with lym-
phatic endothelium26 or splenic platelets and megakaryocytes27. While lymphatic endothelium is not observed 
normally in spleen, transcriptional level expression may indicate that CD31+MAdCAM-1− cells are precursor to 
LYVE-1+ vascular structures observed in the spleen of Nkx2.3−/− mice27.
Mesenchymal lineage pericytes have been implicated in spleen tissue remodeling following lymphocytic cho-
riomeningitis infection23, however a relationship between SPo and pericytes could not be established given a lack 
of both Ng2 and PDGFRb expression (Fig. 6). Interestingly, under grafting and tissue regeneration conditions, 
PDGFRβ -enriched aggregates yielded a higher capacity for tissue formation compared with grafts depleted of 
PDGFRβ + cells (Fig. 4). To determine whether PDGFRβ + cells overlap in identity with SPo, flow cytometry analysis 
was performed but revealed no surface CD31 expression (Supplementary Fig. S1A), confirming PDGFRβ + cells 
represent a distinct stromal subset. Cells expressing PDGFRβ did, however, co-express CD201 at low levels. Thus, 
in CD201-depleted grafts rescued by addition of SPo (Fig. 5), it remains a formal possibility that CD201loPDGFRβ + 
cells avoided magnetic separation to interact with CD31+ SPo during graft formation. Indeed, re-evaluation 
of CD201-depleted stromal cells demonstrated a higher percentage of residual PDGFRβ + cells compared with 
PDGFRβ -depleted stromal preparations (Supplementary Fig. S1B). When considered jointly, these findings indicate 
that both PDGFRβ + and CD31+ SPo cell types may cooperate during neonatal spleen tissue regeneration.
Cell marker












CD45‡ 0.8 (46) 1 + + + 93 0.75 − 
gp38† 0.03 (0.5) 1 + + + 4 1 + + + 
CD31† 0.04 (1) 1 − 4 1 + + + 
CD105† 2 (8.4) 1 + + 29 1 + + + 
CD201† 0.9 (3) 1 + 16 1 + + + 
MAdCAM-1‡ 0.3 (1) 1 + 5 0.25 + + + 
PDGFRβ † 0.1 (1.4) 1 + + 11 0.85 + + + 
Table 1.  Semi-quantitative assessment of 4 week spleen tissue regeneration from single-marker depleted 
or enriched 3-day old spleen cell aggregates. *Percent positive (+ ve) cells before magnetic separation is 
indicated in brackets. #Tissue formation: Absence (− ) or cumulative presence of red pulp (+ ), multiple T/B cell 
segregated white pulp follicles (+ ), marginal zone (+ ). †Data are representative of 2 independent experiments. 
‡Data are representative of 3 or more independent experiments.
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Discussion
Organizer cells in spleen have eluded prior definitive identification although marginal zone reticular cells have 
previously been considered potential SPo candidates. MRC were first described in adult spleen, analogous to 
marginal sinus-lining cells surrounding the white pulp28. In spleen, MRC are thought to represent adult-stage LTo 
since after birth, MAdCAM-1+ cells can be observed concentrated around the central arteriole before expanding 
to form characteristic ring-like structures7. In terms of a prospective role as neonatal MRC, MAdCAM-1+ cells 
isolated from D3 spleen are indeed required for the induction of spleen tissue formation (Table 1). Interestingly, 
aggregate grafts also require cells expressing CD31, reflective of an endothelial lineage. Indeed, MAdCAM-
1+VE-cadherin+ or CD31+ vessels were found to be encircled by CD4+ LTi during embryonic development29,30 
strengthening the notion that stromal cells bordering the mesenchymal and endothelial cell lineages may repre-
sent spleen organizers.
Figure 4. Spleen tissue regeneration of aggregate grafts prepared by magnetic depletion or enrichment 
of stromal cell subsets. Aggregates were depleted (− ) or enriched (+ ) of cells based on single markers before 
transplantation and assessment of tissue regeneration after 4 weeks by immunofluorescence microscopy. 
Representative images of graft development from cell marker depleted or enriched aggregates showing 
comparative efficiencies in formation of full spleen tissue architecture. Top left inserts show enumeration of 
total grafts recovered. Asterisks indicate organized T/B cell white pulp follicles; MZ, marginal zone. Original 
magnification 40× . Scale bar, 500 μ m.
www.nature.com/scientificreports/
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Figure 5. Neonatal CD45−CD31+CD105+CD201+MAdCAM-1+ cells represent spleen organizers. Cell 
markers shown to enrich for spleen forming activity (Table 1) were used to (A) assess D3 neonatal spleen 
sections for stromal cells co-expressing MAdCAM-1 and CD201 or CD31 (arrowheads; scale bar, 50 μ m), and 
(B) identify a single CD45−CD31+CD105+CD201+MAdCAM-1+ stromal population by flow cytometry.  
(C) CD31+ aggregates from D3 spleen capable of tissue regeneration were depleted of CD201 or MAdCAM-1 
expressing cells before aggregation and transplantation to confirm whether spleen forming activity segregated 
with CD31+CD201+ and CD31+MAdCAM-1+ populations. Formation of spleen tissue was assessed 4 weeks 
post-transplant. Each separation and transplantation was performed twice (2–3 grafts/experiment). (D) To 
ascertain bona fide spleen organizers, CD45−CD31+CD201+MAdCAM-1+ cells gated to exclude doublets were 
sorted by FACS and the purity verified (E). CD45−CD31+CD201+MAdCAM-1− and CD45−CD31−CD201hi 
cells were sorted in parallel as negative controls. (F) Sorted populations were re-added to aggregates depleted 
of CD201+ spleen-forming cells before transplantation. Tissues collected after 4 weeks were analyzed by 
immunofluorescence staining with indicated markers (ii, iii and iv, 100× ). Scale bar, 200 μ m. Enlargement of 
(i) (40× ) is shown in (ii). RP, red pulp; MZ, marginal zone; FDC, follicular dendritic cells. No graft formation 
indicates the absence of trace spleen tissue. Data are representative of two independent experiments.
www.nature.com/scientificreports/
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Figure 6. Relative abundance of mRNA transcripts in spleen organizer (SPo) cells. To determine gene expression 
between CD45−CD31+CD201+MAdCAM-1+ (MAdCAM-1+) SPo and CD45−CD31+CD201+MAdCAM-1− 
(MAdCAM-1−) cells that do not induce spleen organogenesis, each population was sorted to purity from D3 spleen 
and assessed for the expression of mRNA by real-time quantitative PCR. CD45+ hematopoietic or CD45− stromal 
cells enriched from adult spleen were used as controls. Gene expression was normalized to β-actin. n = 3, error bars 
indicate SEM. ***P< 0.001; unpaired two-tailed t test.
www.nature.com/scientificreports/
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Identification of a lineage-mixed CD31+CD105+CD201+MAdCAM-1+ organizer cell population here does, 
however, put SPo at odds with LTo commonly thought to derive from a purely mesenchymal origin14,31. Not 
only do MAdCAM-1+ LTo in lymph nodes express PDGFRβ and gp38, recently identified LTo in adipose tissue, 
perivascular FDC precursors, and adult MRC all share similar expression patterns31–33. In contrast, neonatal SPo 
express CD31, CD105 and CD201, lacking PDGFRβ and gp38 expression. Furthermore, compared with embry-
onic spleen Nkx2.5+ organizers23, SPo responsible for spleen regeneration in the present study do not express 
Nkx2.5.
To reconcile these inconsistencies, we propose that neonatal SPo represent an endothelial, or a transitional 
endothelial-mesenchymal population arising from early mesenchymoangioblasts, previously reported to differ-
entiate into both mesenchymal stem cell and endothelial lineages34. This branch in development may result in 
distinct mesenchymal and endothelial-like organizer cell lineages, capable of independently directing embry-
onic23 and neonatal spleen organogenesis, respectively. The requirement for a second population of PDGFRβ + 
stromal organizer cells to initiate spleen regeneration is, however, consistent with mesenchymal lineage Nkx2.5+ 
organizers described by Castagnaro et al. Although we show evidence that PDGFRβ + cells are important for 
spleen tissue neogenesis, the PDGFRβ + population as a whole remains heterogeneous and is known to contain 
pericytes, vascular smooth muscle cells and FDC precursors32. As only a fraction of PDGFRβ + cells are likely to 
represent true organizer cells, further studies are necessary to investigate their precise identity and contribution 
towards spleen organogenesis.
In summary, we have developed a spleen transplant model that facilitates the manipulation of graft cell input, 
and dissected spleen stroma to define a specific MAdCAM-1+CD31+CD201+ organizer cell population essential 
for neonatal spleen regeneration. The ability to shape the cell composition of grafts now enables the role of multi-
ple stromal cell populations which guide spleen development to be investigated. If the minimal cell requirements 
for spleen regeneration can be identified, this may represent a starting point for regenerative therapies targeted at 
repairing or replacing spleen tissue.
Experimental Procedures
Mice. BALB/cCrSlc and Balb/cAnNCrl/Anu mice were purchased from Japan SLC, Inc. and Australian 
Phenomics Facility, Australian National University (ANU), respectively. Mice were housed under specific path-
ogen-free conditions and all methods carried out according to experimental protocols approved by the Kyoto 
University Medical School Animal Experiment Ethics Committee and ANU Animal Experimentation Ethics 
Committee.
Spleen stromal cell aggregates. Spleens were asceptically removed from 3 day-old BALB/c mice and 
dissociated between two sterile microscope slides into PBS. The solution containing a mixture of suspendable 
hematopoietic cells and non-suspendable stromal tissue was filtered through a 100 μ m cell strainer (Becton 
Dickinson), discarding the flow-through. Non-suspendable tissue was transferred into 2 ml supplemented 
DMEM (sDMEM)35 containing 1 mg/ml Collagenase IV (Invitrogen), 40 μ g/ml DNaseI (Sigma) and 2% FBS 
(Gibco) for 20 min at 37 °C with constant stirring to obtain a single-cell suspension18,26. Incubation was repeated 
twice more with addition of medium containing 1 mg/ml Collagenase D (Roche), 40 ug/ml DNaseI (Sigma) 
and 2% FBS before filtration through a 100 μ m cell strainer. Aggregates were formed by resuspending cells at 
5 × 107 cells/ml and drawing 20 μ l of cell solution into a pipette tip subsequently sealed with Parafilm36. Cells 
were pelleted before removal of Parafilm and aspiration of aggregated cells onto a collagen sheet layered over an 
Isopore membrane filter (Millipore) and collagen sponge raft immersed in 1 ml sDMEM for overnight culture at 
37 °C (Fig. 1A). Aggregate/sheet constructs were transplanted under the kidney capsule of 7 week-old splenec-
tomised BALB/c mice at the upper and lower poles of each kidney. After 4 weeks, transplants were collected and 
analyzed by FACS or immunofluorescence staining.
Antibodies and secondary reagents. Antibodies used for cell separation, flow cytometry and immunoflu-
orescence staining are listed in Supplementary Table S2. Secondary reagents are listed in Supplementary Table S3.
Magnetic cell separation. Single-cell suspensions were labeled with appropriate biotin-conjugated anti-
bodies and purified anti-CD16/CD32 Fc Block diluted in labeling buffer (2% FBS/2 mM EDTA in PBS) and 
incubated for 10 mins at 4 °C. Cells were washed once with 10-fold excess volume buffer and incubated with 
anti-biotin microbeads (Miltenyi Biotec). After a second wash, cells were resuspended in buffer and placed inside 
an EasySep Magnet (STEMCELL Technologies). After 10 mins, the magnet was inverted and supernatant contain-
ing unlabeled cells decanted into a fresh tube.
Flow cytometry and cell sorting. For all flow cytometry and cell sorting, propidium iodide (PI; 100 μ g/ml) 
was added to discriminate dead cells. Flow cytometry was performed with FACS CantoII or FACSVerse (BD 
Biosciences) and data analyzed with FlowJo software (TreeStar). Fluorescence-activated cell sorting was per-
formed with FACSAria (BD Biosciences).
Immunostaining. Lymphoid organs and transplants were embedded in Tissue-Tek O.C.T compound 
(Sakura Finetechnical Co., Ltd.) and frozen in liquid nitrogen. Seven micrometre-thick cryostat sections were 
prepared and placed on glass slides (Matsunami Glass Ind. Ltd.). Sections were stored at − 80 °C until use. For 
immunostaining, slides were dried and fixed in acetone for 5 mins, followed by three 5 min washes in PBS. After 
blocking with 1% BSA/0.01%NaN3 in PBS for 30 mins at room temperature, sections were incubated for 1 hour at 
room temperature with appropriate antibodies or secondary fluorochrome-conjugated reagent diluted in block-
ing buffer. Each incubation step was followed by three 5 min washes in PBS. Images were captured on an Axio 
Imager.A2 microscope (Zeiss).
www.nature.com/scientificreports/
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Quantitative RT-PCR (qPCR). Total RNA was isolated with RNeasy Mini Kit (Qiagen) and treated with 
DNase I (Qiagen). cDNA was prepared with PrimeScript RT reagent Kit (Takara). PCR primers used for real-time 
quantitative gene amplification are listed in Supplementary Table S4. PCR reactions were run in triplicates using 
SYBR Premix Ex Taq II (Takara) on a LightCycler480 (Roche). Relative expression levels were normalized to 
β-actin and expressed as mean ± SE.
Statistical analysis. All statistical analyses were performed with Prism (GraphPad Software 6c) using an 
unpaired two-tailed t test or one-way ANOVA with Tukey’s post hoc test. A P value of less than 0.05 was consid-
ered significant.
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